Ekso Other Operating Expenses vs Net Income From Continuing Ops Analysis
EKSO Stock | USD 1.36 0.09 6.21% |
Ekso Bionics financial indicator trend analysis is much more than just examining Ekso Bionics Holdings latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ekso Bionics Holdings is a good investment. Please check the relationship between Ekso Bionics Other Operating Expenses and its Net Income From Continuing Ops accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ekso Bionics Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
Other Operating Expenses vs Net Income From Continuing Ops
Other Operating Expenses vs Net Income From Continuing Ops Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ekso Bionics Holdings Other Operating Expenses account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Ekso Bionics' Other Operating Expenses and Net Income From Continuing Ops is 0.58. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of Ekso Bionics Holdings, assuming nothing else is changed. The correlation between historical values of Ekso Bionics' Other Operating Expenses and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of Ekso Bionics Holdings are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Other Operating Expenses i.e., Ekso Bionics' Other Operating Expenses and Net Income From Continuing Ops go up and down completely randomly.
Correlation Coefficient | 0.58 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Ekso Bionics Holdings. It is also known as Ekso Bionics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Net Income From Continuing Ops
Most indicators from Ekso Bionics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ekso Bionics Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ekso Bionics Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. As of the 19th of May 2024, Sales General And Administrative To Revenue is likely to grow to 1.01, while Selling General Administrative is likely to drop about 8.7 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 6.7M | 6.2M | 9.7M | 5.1M | Total Revenue | 11.2M | 12.9M | 18.3M | 12.3M |
Ekso Bionics fundamental ratios Correlations
Click cells to compare fundamentals
Ekso Bionics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Ekso Bionics fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 21.9M | 20.6M | 49.2M | 40.9M | 28.9M | 26.0M | |
Short Long Term Debt Total | 3.9M | 3.9M | 2.2M | 7.5M | 7.2M | 3.7M | |
Other Current Liab | 1.7M | 1.4M | 2.3M | 2.3M | 2.7M | 2.3M | |
Total Current Liabilities | 7.8M | 5.0M | 6.9M | 9.2M | 8.1M | 6.6M | |
Total Stockholder Equity | 6.8M | 4.4M | 37.2M | 25.4M | 12.6M | 13.6M | |
Net Debt | (7M) | (9.0M) | (38.2M) | (13.0M) | (1.5M) | (1.5M) | |
Retained Earnings | (183.3M) | (199.1M) | (208.9M) | (223.9M) | (239.1M) | (227.2M) | |
Cash | 10.9M | 12.9M | 40.4M | 20.5M | 8.6M | 16.1M | |
Cash And Short Term Investments | 10.9M | 12.9M | 40.4M | 20.5M | 8.6M | 8.2M | |
Common Stock Total Equity | 60K | 63K | 87K | 8K | 9.2K | 8.7K | |
Liabilities And Stockholders Equity | 21.9M | 20.6M | 49.2M | 40.9M | 28.9M | 26.0M | |
Non Current Liabilities Total | 7.3M | 11.2M | 5.1M | 6.3M | 8.2M | 7.4M | |
Total Liab | 15.1M | 16.2M | 11.9M | 15.5M | 16.3M | 13.4M | |
Total Current Assets | 18.8M | 18.4M | 47.8M | 31.0M | 20.2M | 22.1M | |
Short Term Debt | 2.8M | 548K | 229K | 2.7M | 1.6M | 1.1M | |
Common Stock | 63K | 87K | 8K | 13K | 15K | 14.3K | |
Common Stock Shares Outstanding | 4.8M | 7.2M | 12.3M | 13.0M | 13.9M | 14.6M | |
Other Stockholder Equity | 189.9M | 204.4M | 246.1M | 248.8M | 251.6M | 179.6M | |
Other Liab | 6.2M | 7.9M | 3.1M | 1.4M | 1.3M | 1.2M | |
Net Tangible Assets | 6.6M | 4.4M | 37.2M | 19.8M | 22.8M | 15.5M | |
Property Plant And Equipment Net | 2.7M | 1.9M | 1.2M | 4.0M | 3.0M | 2.7M | |
Current Deferred Revenue | 1.5M | 1.5M | 1.2M | 1.1M | 2.0M | 1.4M | |
Accounts Payable | 1.9M | 1.5M | 3.1M | 3.2M | 1.8M | 2.5M | |
Non Current Assets Total | 3.1M | 2.2M | 1.4M | 9.9M | 8.7M | 5.0M | |
Non Currrent Assets Other | 178K | 320K | 164K | 231K | 392K | 504.2K | |
Other Assets | 134K | 178K | 1.0M | 164K | 147.6K | 140.2K | |
Long Term Debt | 407K | 9.1M | 2.0M | 3.8M | 4.8M | 3.8M | |
Net Receivables | 5.2M | 3.4M | 4.7M | 4.6M | 5.6M | 3.9M | |
Long Term Debt Total | 4.8M | 2.6M | 407K | 9.1M | 10.5M | 11.0M | |
Capital Surpluse | 165.8M | 173.9M | 189.9M | 204.4M | 235.0M | 165.0M | |
Inventory | 2.5M | 2.0M | 2.2M | 5.2M | 5.1M | 2.9M | |
Other Current Assets | 238K | 191K | 485K | 700K | 875K | 597.9K | |
Property Plant And Equipment Gross | 2.7M | 1.9M | 1.2M | 4.0M | 6.2M | 6.5M | |
Accumulated Other Comprehensive Income | 50K | (847K) | (17K) | 563K | 156K | 163.8K | |
Property Plant Equipment | 2.7M | 1.2M | 1.2M | 4.0M | 4.6M | 2.6M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ekso Bionics Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Ekso Stock analysis
When running Ekso Bionics' price analysis, check to measure Ekso Bionics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ekso Bionics is operating at the current time. Most of Ekso Bionics' value examination focuses on studying past and present price action to predict the probability of Ekso Bionics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ekso Bionics' price. Additionally, you may evaluate how the addition of Ekso Bionics to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Is Ekso Bionics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ekso Bionics. If investors know Ekso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ekso Bionics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.97) | Revenue Per Share 1.202 | Quarterly Revenue Growth (0.09) | Return On Assets (0.26) | Return On Equity (0.81) |
The market value of Ekso Bionics Holdings is measured differently than its book value, which is the value of Ekso that is recorded on the company's balance sheet. Investors also form their own opinion of Ekso Bionics' value that differs from its market value or its book value, called intrinsic value, which is Ekso Bionics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ekso Bionics' market value can be influenced by many factors that don't directly affect Ekso Bionics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ekso Bionics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ekso Bionics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ekso Bionics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.